Currently there is no effective therapy for dominant optic atrophy, and consequently, these patients are simply monitored for changes in vision by their eye-care professional. Children of patients should be screened regularly for visual changes related to dominant optic atrophy. Research is underway to further characterize the disease so that therapies may be developed. Since November 2018, Cure ADOA Foundation has been focusing on fellow patients and their families. They have the following goals: scientific research, disease awareness, interaction between all parties involved and a trustworthy place for the patients.
Kjer's optic neuropathy
Leber's hereditary optic neuropathy
Graves' ophthalmopathy
Toxic and nutritional optic neuropathy
Arteritic anterior ischemic optic neuropathy
Infiltrative ophthalmopathy
Sorsby's fundus dystrophy
Posterior ischemic optic neuropathy